Related Experiment Video
Updated: Dec 10, 2025

Nucleocapsid Annealing-Mediated Electrophoresis NAME Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
Published on: January 19, 2015
5'-Nor-3-Deaza-1',6'-Isoneplanocin, the Synthesis and Antiviral Study
Qi Chen1, Stewart W Schneller2, Chong Liu2
1Department of Chemistry, Slippery Rock University, Slippery Rock, PA 16057, USA.
Researchers developed a novel synthesis for C-5'-truncated 3-deaza-1',6'-isoneplanocin, yielding compounds with potent antiviral activity against JC virus but not other viruses. These new antiviral agents demonstrated no cytotoxicity.
Area of Science:
- Medicinal Chemistry
- Virology
- Organic Synthesis
Background:
- Aristeromycin and neplanocin are arbocyclic nucleosides investigated for antiviral properties.
- Developing novel antiviral agents remains a critical area in pharmaceutical research.
Purpose of the Study:
- To synthesize C-5 truncated 3-deaza-1 6 -isoneplanocin, combining structural features of 5 -noraristeromycin and 3-deaza-1 6 -isoneplanocin.
- To evaluate the antiviral activity and cytotoxicity of the synthesized compounds.
Main Methods:
- A convenient synthesis route starting from (-)-cyclopentenone.
- Preparation of the two C-4 epimers of 5 -nor-3-deaza isoneplanocin.
- Antiviral assays against JC virus and other DNA/RNA viruses.
- Cytotoxicity assays.
Main Results:
- The synthesis yielded two epimers of 5 -nor-3-deaza isoneplanocin.
- One epimer ((4 'R)-8) showed significant activity against JC virus (EC50 = 1.12 µM).
- Both compounds were inactive against other tested DNA and RNA viruses and exhibited no cytotoxicity.
Conclusions:
- The synthesized C-5 -truncated 3-deaza-1 6 -isoneplanocin derivatives are promising candidates for JC virus treatment.
- Further research may explore modifications to broaden the antiviral spectrum.
- The lack of cytotoxicity is a favorable characteristic for potential therapeutic applications.
Related Concept Videos
Biosynthesis of Nucleic Acids
Subviral Agents
Retroviruses
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Retrovirus Life Cycles
Antimicrobial Effectiveness

